SKI Market

Indian Indices

Sensex

81,031.41 308.47
( 0.38%)

Global Indices

Nasdaq

48,928.31 -164.26
(-0.33%)

Dow Jones

6,963.16 -26.85
(-0.38%)

Hang Seng

53,392.10 16.50
(0.03%)

Nikkei 225

10,214.90 43.14
(0.42%)

Forex

USD-INR

91.66 -0.27
(-0.29%)

EUR-INR

108.61 -1.36
(-1.24%)

GBP-INR

125.41 -1.53
(-1.21%)

JPY-INR

0.59 -0.01
(-1.35%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Venus Remedies Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

526953

INE411B01019

467.2458657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VENUSREM

15.73

1111.4

EPS(TTM)

Face Value()

Div & Yield %

52.85

Back

Sparkle Gold Rock reports standalone net profit of Rs 0.81 crore in the December 2025 quarter

Jan 30,2026

Net profit of Sparkle Gold Rock reported to Rs 0.81 crore in the quarter ended December 2025 as against net loss of Rs 0.05 crore during the previous quarter ended December 2024. Sales rose 1905.70% to Rs 45.73 crore in the quarter ended December 2025 as against Rs 2.28 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	45.73	2.28	1906
OPM %	2.91	-2.19	-
PBDT	1.33	-0.05	LP
PBT	1.33	-0.05	LP
NP	0.81	-0.05	LP

81,031.41 308.47 ( 0.38%)

48,928.31 -164.26 (-0.33%)

6,963.16 -26.85 (-0.38%)

53,392.10 16.50 (0.03%)

10,214.90 43.14 (0.42%)

91.66 -0.27 (-0.29%)

108.61 -1.36 (-1.24%)

125.41 -1.53 (-1.21%)

0.59 -0.01 (-1.35%)